A detailed history of Schroder Investment Management Group transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 3,203 shares of SRPT stock, worth $381,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,203
Previous 37,261 91.4%
Holding current value
$381,605
Previous $5.89 Million 93.21%
% of portfolio
0.0%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$124.33 - $156.75 $4.23 Million - $5.34 Million
-34,058 Reduced 91.4%
3,203 $400,000
Q2 2024

Aug 12, 2024

BUY
$113.33 - $163.85 $2.28 Million - $3.29 Million
20,075 Added 116.81%
37,261 $5.89 Million
Q1 2024

May 14, 2024

SELL
$93.7 - $141.53 $891,461 - $1.35 Million
-9,514 Reduced 35.63%
17,186 $2.22 Million
Q4 2023

Feb 13, 2024

BUY
$67.31 - $124.76 $1.8 Million - $3.33 Million
26,700 New
26,700 $2.57 Million
Q2 2021

Aug 13, 2021

SELL
$69.38 - $86.75 $125,369 - $156,757
-1,807 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$125.56 - $178.74 $151,174 - $215,202
1,204 Added 199.67%
1,807 $308,000
Q2 2020

Aug 13, 2020

BUY
$93.0 - $171.7 $21,297 - $39,319
229 Added 61.23%
603 $97,000
Q1 2020

May 15, 2020

BUY
$82.38 - $131.64 $30,810 - $49,233
374 New
374 $38,000
Q3 2019

Nov 12, 2019

SELL
$72.81 - $156.91 $87,444 - $188,448
-1,201 Closed
0 $0
Q2 2019

Aug 08, 2019

SELL
$112.21 - $151.95 $125,338 - $169,728
-1,117 Reduced 48.19%
1,201 $182,000
Q1 2019

May 14, 2019

BUY
$106.67 - $151.68 $247,261 - $351,594
2,318 New
2,318 $276,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.